SOX2 and breast carcinoma: In conclusion, we report here that the stem cell pluripotency factor Sox2 is commonly expressed in feline mammary carcinomas, is associated with higher proliferation, decreased PR and FOXA1, but higher AR expression, as well as poor outcomes.